GOLDMAN SACHS GROUP INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 49 filers reported holding RECRO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2023$49,743
-1.9%
45,221
+6.1%
0.00%
Q1 2023$50,714
-26.0%
42,617
-7.3%
0.00%
Q4 2022$68,515
+197.9%
45,983
+257.9%
0.00%
Q1 2022$23,000
+27.8%
12,847
+19.7%
0.00%
Q4 2021$18,000
-81.4%
10,730
-77.1%
0.00%
Q3 2021$97,000
-11.0%
46,895
-0.4%
0.00%
Q2 2021$109,000
+202.8%
47,078
+260.4%
0.00%
Q1 2021$36,000
-28.0%
13,064
-24.8%
0.00%
Q4 2020$50,000
-84.8%
17,372
-88.9%
0.00%
Q3 2020$330,000
-0.9%
157,066
+114.9%
0.00%
Q2 2020$333,000
-41.4%
73,093
+5.1%
0.00%
Q1 2020$568,000
-10.4%
69,526
+101.3%
0.00%
Q4 2019$634,000
-3.9%
34,542
-42.0%
0.00%
Q3 2019$660,000
-35.4%
59,558
-40.8%
0.00%
Q2 2019$1,022,000
+176.2%
100,573
+59.3%
0.00%
Q1 2019$370,000
+2.2%
63,148
+23.9%
0.00%
Q4 2018$362,000
+306.7%
50,975
+305.1%
0.00%
Q3 2018$89,000
-84.1%
12,582
-75.2%
0.00%
Q1 2018$559,000
+9.8%
50,793
-10.4%
0.00%
Q3 2017$509,000
+20.0%
56,658
-6.0%
0.00%
Q2 2017$424,000
+282.0%
60,276
+373.9%
0.00%
Q1 2017$111,000
-61.7%
12,719
-64.7%
0.00%
Q4 2016$290,00036,0410.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders